EichorEICHOR
Location: New Haven Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near New Haven

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Yale-New Haven Hospital · Eli Lilly and Company · NCT07218380MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Yale University · National Cancer Institute (NCI) · NCT05564390A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Yale New Haven Hospital-Smilow Cancer Center · Bristol-Myers Squibb · NCT06929273Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep
Phase 4 · Yale New Haven Health · Yale University · NCT05612594Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996The DRAGON 2 Trial
NA · Yale New Haven Hospital · Maastricht University · NCT05428735Non-invasive Venous Pressure Estimation
NA · Yale New Haven Hospital CICU · Yale University · NCT07226479A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced
Phase 1 · Yale Cancer Center- New Haven · Kumquat Biosciences Inc. · NCT06994806Regulation of Brain Glucose Metabolism in Type 1 Diabetes
EARLY_Phase 1 · Yale-New Haven Hospital · Yale University · NCT05317455A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 · Smilow Cancer Hospital - Yale New Haven Health · Pfizer · NCT07090499Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study
Phase 2 · Yale New Haven Hospital Saint Raphael Campus · Yale University · NCT05279092StrokeNet Thrombectomy Endovascular Platform
NA · Yale New Haven Hospital · Medical University of South Carolina · NCT06289985STIMIT Activator 1 IDE Study
NA · Yale New Haven Hospital · Stimit AG · NCT05883163A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide
Phase 1/Phase 2 · Yale New Haven Hospital-Smilow Cancer Center · Celgene · NCT06988488MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Agendia · NCT03053193Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · Yale New Haven Hospital · Amgen · NCT04221542Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients
NA · Yale New Haven Hospital · Yale University · NCT05784805Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation
NA · Yale New Haven Hospital Saint Raphael's Campus · Yale University · NCT06407427Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Yale University · SWOG Cancer Research Network · NCT06769126Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
NA · Yale New Haven Children's Hospital · Meyer Children's Hospital IRCCS · NCT06921993Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants
Phase 1 · Pfizer Clinical Research Unit - New Haven · Pfizer · NCT07215078A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Yale New Haven Hospital · Amgen · NCT07005128A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · Eli Lilly and Company · NCT05986292Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Smilow Cancer Center/Yale-New Haven Hospital · NRG Oncology · NCT05174169Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Phase N/A · Yale-New Haven Health System · Novartis Pharmaceuticals · NCT04174157A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Smilow Cancer Hospital at Yale-New Haven · Takeda · NCT06499285ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Yale University · Alliance for Clinical Trials in Oncology · NCT06876714Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2
Phase 2 · Yale New Haven Hospital Saint Raphael Campus · Yale University · NCT05736549Comparison of Uncomplicated Candidemia Therapy Duration in Children
NA · Yale New Haven Children's Hospital · Arkansas Children's Hospital Research Institute · NCT05763251
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.